The Scientist

» herpesvirus

Most Recent

The CEO of a biomedical startup had made headlines this year when he injected himself with an untested herpes vaccine in front of an audience.

0 Comments

image: Some Antibiotics Rev Up Host Immune Response to Viruses

Some Antibiotics Rev Up Host Immune Response to Viruses

By Shawna Williams | April 9, 2018

The antimicrobial drug neomycin protects mice from some viral infections, complicating the picture of the relationship between antibiotics and susceptibility to viruses.

2 Comments

image: Recipients of Experimental Herpes Vaccine File Lawsuit

Recipients of Experimental Herpes Vaccine File Lawsuit

By Catherine Offord | March 15, 2018

The suit claims that Rational Vaccines, the company of recently deceased researcher William Halford, violated US and international laws when it carried out the procedure.

0 Comments

image: Biohacker Injects DIY Herpes Vaccine on Facebook Live

Biohacker Injects DIY Herpes Vaccine on Facebook Live

By Shawna Williams | February 5, 2018

The stunt, performed at a biohacking conference, was purportedly part of a two-subject trial of the genetically modified vaccine.

0 Comments

image: Scientists Look to Epigenetics to Thwart Viruses

Scientists Look to Epigenetics to Thwart Viruses

By Shawna Williams | September 1, 2017

Some viral pathogens modify chromatin and other epigenetic machinery, making them appealing drug targets.

0 Comments

image: Five Oncoviruses Debut On NIH Carcinogen List

Five Oncoviruses Debut On NIH Carcinogen List

By Joshua A. Krisch | November 7, 2016

Seven newly evaluated substances, including five oncoviruses, have been added to the US National Institutes of Health’s 14th Report on Carcinogens.

0 Comments

image: CRISPR Combats Herpes

CRISPR Combats Herpes

By Alison F. Takemura | July 5, 2016

Scientists use the gene editing technology to target active and latent virus in mammalian cell cultures.

0 Comments

image: FDA OKs Herpesvirus to Treat Cancer

FDA OKs Herpesvirus to Treat Cancer

By Jef Akst | October 28, 2015

The US Food and Drug Administration’s approval of an engineered herpesvirus for the treatment of melanoma marks the first oncolytic virus to enter the market.

0 Comments

image: Herpes Vax Shows Promise

Herpes Vax Shows Promise

By Jef Akst | March 12, 2015

A vaccine candidate against herpes simplex virus type 2 provides complete protection against infection in mice, with no evidence of latent virus.

1 Comment

image: Have Herpes, Will Travel

Have Herpes, Will Travel

By Abby Olena | April 1, 2014

Insight into the geographical clustering of a viral genome comes from an unexpected source.

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process